X0306 4 2015-03-10 0 0001512762 Coherus BioSciences, Inc. CHRS 0001420822 Lanfear Dennis M COHERUS BIOSCIENCES, INC. 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065 1 1 0 0 President & CEO Common Stock, $0.0001 par value 2015-03-10 4 J 0 799 0.00 A 1342720 I By Trust Common Stock, $0.0001 par value 2015-03-10 4 J 0 828 0.00 A 69551 D Common Stock, $0.0001 par value 2015-03-10 4 J 0 4 0.00 A 86952 I By LLC On March 10, 2015, Reporting Person and Reporting Person's Trust and Limited Liability Company became entitled to receive shares of Issuer's common stock pursuant to the release of shares from escrow pursuant to the terms and conditions of that certain Agreement and Plan of Merger by and among Issuer, Coherus Intermediate Corp., Coherus Acquisition Corp., InteKrin Therapeutics Inc. ("InteKrin") and Fortis Advisors LLC, dated as of January 8, 2014 ("Merger Agreement"), pursuant to which Issuer acquired InteKrin. The shares issued to Reporting Person had been held in escrow for satisfaction to the indemnification obligations of the former stockholders of InteKrin to Issuer. The release of the shares issued to Reporting Person by the escrow agent was executed on March 10, 2015 upon determination by the escrow agent under the Merger Agreement, stockholders' representative under the Merger Agreement and transfer agent to Issuer that all conditions for such release had been satisfied. These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President. /s/ Matthew R. Hooper, as Attorney-in-Fact for Dennis M. Lanfear 2015-03-12